TM4-B Inhibitors
Chemical inhibitors of TM4-B can exert their effects by targeting various components of the cellular infrastructure and signaling pathways with which TM4-B interacts. Phalloidin, for instance, acts by stabilizing F-actin filaments, which could inhibit the ability of TM4-B to engage with the cytoskeleton, thereby hindering its function. Colchicine, by contrast, binds to tubulin, impeding the polymerization of microtubules, which are essential for cellular transport and structure. Since the function of TM4-B may be contingent on the microtubule network's integrity for its localization or trafficking within the cell, colchicine's actions can result in the functional inhibition of TM4-B. Cytochalasin D disrupts actin polymerization; if TM4-B requires an intact actin cytoskeleton for its operations, this chemical's role in preventing actin filament formation can lead to an inhibition of TM4-B's activity.
Other agents target the dynamic nature of the cytoskeleton and associated proteins. Blebbistatin inhibits myosin II ATPase activity, potentially affecting TM4-B if it depends on myosin for processes such as cell movement or vesicle transport. Similarly, ML-7 targets myosin light chain kinase (MLCK), which can influence TM4-B function if it is associated with MLCK-regulated processes. Go6976 serves as an inhibitor of Protein Kinase C (PKC), and if TM4-B is part of the PKC signaling pathway, its inhibition can restrict TM4-B's activity. Kinase inhibitors like PD 98059 and SB 203580, which selectively inhibit MEK and p38 MAP kinase respectively, can also interfere with TM4-B's function if it is regulated by the MAPK pathway. LY294002, which inhibits phosphoinositide 3-kinases (PI3K), can affect TM4-B's role in PI3K-regulated signaling or trafficking. Additionally, NF449, a selective inhibitor of the Gs-alpha subunit of G-protein, can impair TM4-B's function if it is involved in G-protein coupled receptor pathways. Lastly, W7, a calmodulin antagonist, can impede TM4-B's activity if it relies on calmodulin-mediated mechanisms, such as calcium signaling or the modulation of calcium-dependent enzymes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin stabilizes F-actin, and since TM4-B is a transmembrane protein potentially involved in cytoskeletal organization, stabilizing actin filaments could inhibit TM4-B's ability to interact with the cytoskeleton, leading to functional inhibition. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds tubulin, preventing microtubule polymerization. TM4-B may rely on the microtubule network for trafficking or localization, so inhibiting microtubule dynamics can inhibit TM4-B function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization. If TM4-B requires actin structures for its function, the disruption of actin polymerization could inhibit the protein's functional capabilities. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II ATPase activity. If TM4-B's function is dependent on myosin-driven processes such as cell motility or vesicle transport, inhibition of myosin II can result in inhibition of TM4-B function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits the Rho-associated protein kinase (ROCK). If TM4-B is involved in pathways regulated by ROCK, such as cell shape or motility, the chemical's inhibition of ROCK can lead to TM4-B functional inhibition. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK). If the function of TM4-B is associated with MLCK activity, such as in smooth muscle contraction or cell adhesion, ML-7 can inhibit TM4-B function through MLCK inhibition. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a potent inhibitor of Protein Kinase C (PKC). If TM4-B is part of signaling pathways involving PKC, inhibition by Go6976 could lead to downstream inhibition of TM4-B's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK, which is upstream of ERK in the MAPK pathway. If TM4-B's function is modulated by the MAPK pathway, inhibiting MEK with PD 98059 could lead to functional inhibition of TM4-B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 selectively inhibits p38 MAP kinase. If TM4-B's activity is regulated through the p38 MAPK stress response pathway, inhibiting this kinase can lead to functional inhibition of TM4-B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). If TM4-B is involved in signaling pathways or trafficking processes regulated by PI3K, LY294002's inhibition of PI3K can inhibit TM4-B function. | ||||||